RODMAN&RENSHAW upgraded shares of Rockwell Medical (NASDAQ:RMTI – Free Report) to a strong-buy rating in a report published on Thursday,Zacks.com reports. A number of other analysts have also weighed ...

Fintel reports that on November 14, 2024, Rodman & Renshaw initiated coverage of Rockwell Medical (NasdaqCM:RMTI) with a Buy ...

Rodman & Renshaw initiated coverage of Rockwell Medical (RMTI) with a Buy rating and $5 price target Rockwell has been a leading provider ...

On Wednesday, Rockwell Medical Inc (RMTI) stock saw a decline, ending the day at $2.63 which represents a decrease of $-0.20 or -7.07% from the prior close of $2.83. The stock opened at $3 and touched ...

Anthony Vendetti, an analyst from Maxim Group, maintained the Buy rating on Rockwell Med (RMTI – Research Report). The associated price ...

Rockwell Medical (RMTI) stock could double by 2027 despite recent selloff, says Seeking Alpha analyst. Read more here.

However, my previous bullish call almost broke even last week - this was thwarted by the price action following the Q3 FY2024 ...

Cash Flow from Operations: $4.3 million for Q3 2024. Rockwell Medical Inc (NASDAQ:RMTI) achieved profitability on a cash flow and adjusted EBITDA basis for the second consecutive quarter. The company ...

Piper Jaffray has recently initiated Rockwell Medical Inc (RMTI) stock to Overweight rating, as announced on June 24, 2019, according to Finviz. Earlier, on May 13, 2019, H.C. Wainwright had initiated ...

Rockwell Medical (RMTI) delivered earnings and revenue surprises of 400% and 8.95%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical Inc. (RMTI) on Tuesday reported net income of $1.7 million in its third quarter. The Wixom, Michigan-based company said it had net income of 5 cents per share. The maker of products ...

Analysts anticipate Rockwell Medical to report an earnings per share (EPS) of $0.01. The market awaits Rockwell Medical's ...